LOC100271831 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.355000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.466400E-01
Normal-vs-Stage2
6.840800E-01
Normal-vs-Stage3
9.426000E-01
Normal-vs-Stage4
7.939600E-01
Stage1-vs-Stage2
3.046000E-01
Stage1-vs-Stage3
5.834800E-01
Stage1-vs-Stage4
3.986000E-01
Stage2-vs-Stage3
6.107800E-01
Stage2-vs-Stage4
7.423400E-01
Stage3-vs-Stage4
7.621200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.242400E-01
Normal-vs-AfricanAmerican
7.159000E-01
Normal-vs-Asian
5.071700E-02
Caucasian-vs-AfricanAmerican
2.406600E-01
Caucasian-vs-Asian
6.062300E-02
AfricanAmerican-vs-Asian
4.216400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.197200E-01
Normal-vs-Female
7.501400E-01
Male-vs-Female
3.804800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.018000E-01
Normal-vs-Age(41-60Yrs)
9.938800E-01
Normal-vs-Age(61-80Yrs)
6.695200E-01
Normal-vs-Age(81-100Yrs)
3.415600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.198400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.086800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.181500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.563800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.994400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.176400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.705400E-01
Normal-vs-Daily Drinker
6.013700E-02
Normal-vs-Weekly Drinker
3.729200E-01
Normal-vs-Occasional Drinker
8.260800E-01
Normal-vs-Social Drinker
9.367000E-01
Non Drinker-vs-Daily Drinker
7.296500E-02
Non Drinker-vs-Weekly Drinker
4.207600E-01
Non Drinker-vs-Occasional Drinker
9.167400E-01
Non Drinker-vs-Social Drinker
9.526200E-01
Daily Drinker-vs-Weekly Drinker
7.580800E-01
Daily Drinker-vs-Occasional Drinker
8.641700E-02
Daily Drinker-vs-Social Drinker
1.064750E-01
Weekly Drinker-vs-Occasional Drinker
4.409000E-01
Weekly Drinker-vs-Social Drinker
4.316600E-01
Occasional Drinker-vs-Social Drinker
9.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.081600E-01
Normal-vs-Grade 2
3.883000E-01
Normal-vs-Grade 3
4.496200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.038600E-01
Grade 1-vs-Grade 3
7.691600E-01
Grade 1-vs-Grade 4
6.081600E-01
Grade 2-vs-Grade 3
3.544800E-01
Grade 2-vs-Grade 4
3.883000E-01
Grade 3-vs-Grade 4
4.496200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.588400E-01
Normal-vs-NonDiabetic
7.543600E-01
Diabetic-vs-NonDiabetic
4.983200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.087400E-01
Normal-vs-NoPancreatitis
7.410600E-01
Pancreatitis-vs-NoPancreatitis
6.519400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.730800E-01
Normal-vs-N1
7.701800E-01
N0-vs-N1
4.533400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.797740E-02
Normal-vs-TP53-NonMutant
4.817400E-01
TP53-Mutant-vs-TP53-NonMutant
4.160000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
